8-K: AlphaTime Secures $11.5M PIPE for HCYC Merger

AlphaTime Acquisition Corp announced a private placement of $11.5 million in ordinary shares and warrants to fund its business combination with HCYC Group Company Limited.

Summary

• AlphaTime Acquisition Corp (ATMC) entered into Securities Purchase Agreements for a Private Investment in Public Equity (PIPE) financing.
• The PIPE financing totals $11.5 million, consisting of ordinary shares and accompanying warrants.
• 1,150,000 ordinary shares are being sold at $10.00 per share.
• Warrants to purchase up to 2,300,000 ordinary shares are being issued, exercisable at $10.00 per share for five years.
• The financing is in connection with ATMC's previously announced business combination with HCYC Group Company Limited.
• Amended and Restated PIPE Agreements were executed on September 16, 2025, to include HCYC Holding Company as a party.
• The PIPE Shares and Warrant Shares are subject to registration rights, requiring ATMC to file a registration statement within 15 calendar days of closing and use best efforts for effectiveness within 60-120 days.
• Securities are being offered under exemptions from registration (Section 4(a)(2), Regulation D, Regulation S) to accredited investors and/or non-U.S. persons.

Sentiment

Score: 7

Explanation: The filing details a successful PIPE financing, which is a positive step towards completing the business combination. While dilution is a factor, securing capital for a SPAC merger is generally viewed favorably, indicating progress and investor support for the underlying transaction. The terms appear standard for such a transaction, with some protective provisions for investors but also potential for future dilution.

Positives

• Secured $11.5 million in PIPE financing, indicating investor confidence in the upcoming business combination.
• The financing is a crucial step towards completing the business combination with HCYC Group Company Limited.
• Registration rights for PIPE investors provide a clear path for liquidity.
• Warrants are immediately exercisable and have a five-year term, offering long-term upside potential for investors.

Negatives

• Potential for dilution of existing ordinary shares due to the issuance of new shares and warrants.
• The exercise price of the warrants ($10.00) is subject to adjustment, including a 'Reset Date' adjustment to 20% of the Nasdaq Minimum Price, which could lead to a lower exercise price and further dilution if the stock price declines.
• Liquidated damages provisions for the company if it fails to meet registration deadlines or maintain public information requirements, adding potential financial penalties.

Risks

• Dilution Risk: The issuance of PIPE Shares and Warrant Shares may result in substantial dilution of outstanding ordinary shares.
• Market Price Impact: Past or future open market transactions by purchasers, including short sales or derivative transactions, may negatively impact the market price of the company's publicly-traded securities.
• Registration Failure Penalties: Failure to file a registration statement on time, achieve effectiveness, or maintain continuous effectiveness will result in liquidated damages payable to holders.
• Public Information Failure: If the company fails to satisfy current public information requirements under Rule 144, it will incur liquidated damages.
• Business Combination Risk: The PIPE financing is contingent on the closing of the business combination with HCYC Group Company Limited, which may not occur.
• Warrant Exercise Price Reset: The warrant exercise price is subject to adjustment to a 'Reference Price' (20% of Nasdaq Minimum Price) on the Reset Date, which could be lower than the initial $10.00, leading to further dilution.
• Share Combination Event Adjustment: A share combination event could lead to a reduction in the exercise price if the Event Market Price is lower than the current exercise price, increasing the number of warrant shares issuable.

Future Outlook

The PIPE financing is expected to close substantially concurrently with the closing of the business combination with HCYC Group Company Limited, subject to the satisfaction of customary closing conditions. The company is obligated to file a registration statement for the resale of the PIPE shares and warrant shares within 15 calendar days of closing and aim for effectiveness within 60-120 days.

Management Comments

• The Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Ordinary Shares a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.
• The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the Ordinary Shares may be listed.
• The Company covenants that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof.

Industry Context

This PIPE financing is typical for a Special Purpose Acquisition Company (SPAC) nearing the completion of its de-SPAC transaction. It provides additional capital to the target company (HCYC) and helps ensure sufficient funds for the combined entity's operations post-merger, a common practice to bolster balance sheets and satisfy minimum cash conditions for business combinations.

Stakeholder Impact

• Shareholders: Existing shareholders face potential dilution from the issuance of new shares and warrants.
• PIPE Investors: Will receive ordinary shares and warrants, with registration rights for liquidity, but are subject to beneficial ownership limitations and potential exercise price adjustments.
• HCYC Group Company Limited: Benefits from the capital infusion, which is crucial for the completion of the business combination.
• Company (AlphaTime Acquisition Corp): Secures necessary funding for the business combination and incurs obligations related to registration and potential liquidated damages.

Next Steps

• Closing of the PIPE Financing, expected substantially concurrently with the Business Combination.
• Completion of the business combination with HCYC Group Company Limited.
• Company to file a registration statement with the SEC covering the resale of the PIPE Shares and ordinary shares issuable upon exercise of the PIPE Warrants within 15 calendar days following the closing of the PIPE Financing.
• Company to use best efforts to have the registration statement declared effective within 60 calendar days (or 120 days in case of full SEC review) following the closing.
• HCYC Holding Company will assume all obligations of AlphaTime Acquisition Corp under the agreements upon consummation of the Business Combination.

Key Dates

Recommendation

The PIPE financing is a necessary and expected step for AlphaTime Acquisition Corp to complete its business combination with HCYC. While securing $11.5 million is positive for the merger's progression, the terms include significant potential for dilution from both the shares and warrants, especially with the warrant exercise price reset mechanism. The success of the investment hinges entirely on the underlying value and future performance of HCYC post-merger, which is not detailed in this filing. Investors should hold and await further information on HCYC's business fundamentals and the combined entity's prospects before making a definitive buy or sell decision. The immediate impact is likely neutral to slightly negative due to dilution concerns, but the long-term outlook depends on the successful integration and performance of the target company.

Keywords

AlphaTime Acquisition Corp, HCYC Group Company Limited, HCYC Holding Company, PIPE Financing, Private Placement, SPAC, Business Combination, Merger, Warrants, Ordinary Shares, SEC Filing, Form 8-K, Registration Rights, Accredited Investors, Dilution, Nasdaq